A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection
Clinical trial NCT06593626 · COMPLETED
Trial details
- NCT number
- NCT06593626
- Sponsor
- HTA Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2025-06-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.